Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20.9M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+423K
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$44.2M
-
Put/Call ratio
-
0.81
-
Number of buys
-
71
-
Number of sells
-
-58
-
Price
-
$57.54
Significant Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q3 2024
159 filings reported holding PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK as of Q3 2024.
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 20.9M outstanding shares and own 90.23% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.3M shares), PERCEPTIVE ADVISORS LLC (1.16M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.12M shares), VANGUARD GROUP INC (1.04M shares), Point72 Asset Management, L.P. (1.03M shares), Capital Research Global Investors (997K shares), Cormorant Asset Management, LP (870K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (854K shares), STATE STREET CORP (790K shares), and RA CAPITAL MANAGEMENT, L.P. (762K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.